Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial..  Journal of Bone and Mineral Research.  33:763-772. 2018
2017 Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study..  Osteoporosis International.  28:2505. 2017
2017 Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study..  Osteoporosis International.  28:2495-2503. 2017
2016 A multi-modal intervention for Activating Patients at Risk for Osteoporosis (APROPOS): Rationale, design, and uptake of online study intervention material..  Contemporary Clinical Trials Communications.  4:14-24. 2016
2016 Understanding practice-based research participation: The differing motivations of engaged vs. non-engaged clinicians in pragmatic clinical trials..  Contemporary Clinical Trials Communications.  4:136-140. 2016
2016 A pragmatic randomized trial comparing tablet computer informed consent to traditional paper-based methods for an osteoporosis study..  Contemporary Clinical Trials Communications.  3:32-38. 2016
2016 Medical therapy for osteoporosis and approaches to improving adherence.  JCOM.  23:329-336. 2016
2016 Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients..  Current Opinion in HIV and AIDS.  11:351-357. 2016
2015 An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users..  Journal of Rheumatology.  42:1478-1483. 2015
2015 Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels..  AIDS Research and Treatment.  2015:478750. 2015
2014 Bone alterations associated with HIV..  Current HIV/AIDS Reports.  11:233-240. 2014
2014 HIV-related metabolic comorbidities in the current ART era..  Infectious Disease Clinics of North America.  28:457-476. 2014
2014 Effect of self-referral on bone mineral density testing and osteoporosis treatment..  Medical Care.  52:743-750. 2014
2014 Molecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis..  PLoS ONE.  9:e102706. 2014
2013 Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids..  Current Opinion in Endocrinology and Diabetes.  20:510-516. 2013
2013 Prevention and treatment of bone changes associated with exposure to glucocorticoids..  Current Osteoporosis Reports.  11:341-347. 2013
2013 Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfect..  Journal of Rheumatology.  40:1640-1642. 2013
2013 Study design considerations for a large simple trial of bisphosphonates..  Current Opinion in Rheumatology.  25:517-523. 2013
2013 Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort..  American Journal of the Medical Sciences.  345:446-454. 2013
2013 Osteoporosis diagnosis and medical treatment..  Orthopedic Clinics of North America.  44:125-135. 2013
2013 Using tablet computers compared to interactive voice response to improve subject recruitment in osteoporosis pragmatic clinical trials: feasibility, satisfaction, and sample size..  Patient Preference and Adherence.  7:517-523. 2013
2012 A randomized trial of a mailed intervention and self-scheduling to improve osteoporosis screening in postmenopausal women..  Journal of Bone and Mineral Research.  27:2603-2610. 2012
2012 Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States..  Controlled Clinical Trials.  33:1211-1216. 2012
2011 Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary?.  Current Osteoporosis Reports.  9:122-128. 2011
2011 Which fractures are most attributable to osteoporosis?.  Journal of Clinical Epidemiology.  64:46-53. 2011
2010 Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death..  Journal of the American Medical Directors Association.  11:584-591. 2010
2010 Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication..  PLoS ONE.  5:e12617. 2010
2010 Bone changes and fracture risk in individuals infected with HIV..  Current Rheumatology Reports.  12:163-169. 2010
2009 "Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures?.  Osteoporosis International.  20:1969-1972. 2009
2009 Adherence to osteoporosis treatments: room for improvement..  Current Opinion in Rheumatology.  21:356-362. 2009
2009 Management of osteoporosis among home health and long-term care patients with a prior fracture..  Southern Medical Journal.  102:397-404. 2009
2008 Improving quality of care in osteoporosis: opportunities and challenges..  Current Rheumatology Reports.  10:123-130. 2008
2007 Challenges in defining and improving osteoporosis quality of care.  Clinical and Experimental Rheumatology.  25. 2007

Chapter

Year Title Altmetric
2009 Osteoporosis.  393-404. 2009

Principal Investigator On

Investigator On

  • Private Grant  awarded by Sanofi US Services Inc 2018 - 2025
  • Private Grant  awarded by CHIASMA, INC. 2017 - 2022
  • Private Grant  awarded by KOWA 2017 - 2022
  • Private Grant  awarded by ASTRAZENECA AB 2017 - 2022
  • Private Grant  awarded by THERACOS SUB, LLC 2017 - 2022
  • Private Grant  awarded by GAN & LEE PHARMACEUTICAL 2018 - 2022
  • Private Grant  awarded by GAN & LEE PHARMACEUTICAL 2018 - 2022
  • Private Grant  awarded by Sanofi US Services Inc 2018 - 2022
  • Private Grant  awarded by IRONWOOD PHARMACEUTICALS, INC. 2018 - 2022
  • Private Grant  awarded by IONIS PHARMACEUTICALS, INC. 2018 - 2021
  • Private Grant  awarded by Sanofi US Services Inc 2016 - 2021
  • Private Grant  awarded by MEREO BIOPHARMA 3 LIMITED 2017 - 2020
  • Private Grant  awarded by Sanofi US Services Inc 2016 - 2020
  • Private Grant  awarded by MILLENDO THERAPEUTICS 2017 - 2020
  • Private Grant  awarded by XERIS PHARMACEUTICALS 2018 - 2020
  • Private Grant  awarded by NOVO NORDISK PHARMACEUTICALS, INC. 2016 - 2020
  • Private Grant  awarded by Sanofi US Services Inc 2017 - 2020
  • Implementation of Direct-to-Patient Telemedicine Healthcare Initiatives  awarded by UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION 2017 - 2019
  • Private Grant  awarded by CHIASMA, INC. 2016 - 2019
  • Private Grant  awarded by ASTRAZENECA AB 2013 - 2019
  • Private Grant  awarded by XERIS PHARMACEUTICALS 2017 - 2019
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2018
  • Private Grant  awarded by Sanofi US Services Inc 2016 - 2018
  • Private Grant  awarded by NOVO NORDISK PHARMACEUTICALS, INC. 2014 - 2018
  • Cardiovascular Inflammation Reduction Trial (CIRT): A Randomized Double-Blind Placebo-Controlled, Event-Driven Trial of Weekly Low-Dose Methotrexate (LDM) in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients  awarded by Brigham and Women's Hospital 2013 - 2018
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2018
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2016
  • Private Grant  awarded by Pfizer Pharmaceuticals 2014 - 2016
  • Private Grant  awarded by MERCK & COMPANY, INC. 2013 - 2016
  • Pilot Studies for the Active Comparator Osteoporosis Large Simple Trial (ATLAST)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2012 - 2016
  • Private Grant  awarded by GI DYNAMICS, INC. 2013 - 2016
  • Diabetic Macular Edema Found by OCT Utilization at Non-Ophthalmic Diabetes Care Visits  awarded by Joslin Diabetes Center 2014 - 2016
  • Effectiveness of DiscontinuinG BisphosphonatEs Study (EDGE)  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2013 - 2016
  • Private Grant  awarded by BIODEL, INC. 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012 - 2015
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2015
  • Private Grant  awarded by NOVO NORDISK PHARMACEUTICALS, INC. 2014 - 2015
  • Private Grant  awarded by PROLOR BIOTECH 2013 - 2014
  • Private Grant  awarded by MERCK & COMPANY, INC. 2013 - 2014
  • NIAMS Multidiscipllinary Clinical Research Center  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2008 - 2014
  • NIAMS Multidiscipllinary Clinical Research Center - Project 4  awarded by National Institute of Arthritis & Musculoskeletal & Skin Diseases/NIH/DHHS 2008 - 2014
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012 - 2014
  • Private Grant  awarded by Janssen 2013 - 2014
  • A Study of the Genetic Causes of Latent Autoimmune Diabetes in Adults  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2012 - 2014
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2012 - 2013

    • Education And Training

  • Doctor of Medicine in Endocrinology, Diabetes and Metabolism Residency Program, University of Arkansas

    • Full Name

  • Amy Warriner

    • Blazerid

  • warriner